CHRISTOPHER RICHARD
Insider CIK 1271244 · NVIV Chief Financial Officer · LEXX Chief Executive Officer, Director · ICAD Executive VP and CFO · DUSA VP Finance & CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LEXX Lexaria Bioscience Corp. | P Buy | 2025-07-29 | 2025-07-30 | 15,000 | $0.91 | $13.7K | 65,000 | SEC↗ |
| LEXX Lexaria Bioscience Corp. | A Award deriv | 2025-05-15 | 2025-05-16 | 150,000 | — | $0 | 350,000 | SEC↗ |
| LEXX Lexaria Bioscience Corp. | P Buy | 2024-12-03 | 2024-12-03 | 27,172 | $2.47 | $67.1K | 50,000 | SEC↗ |
| LEXX Lexaria Bioscience Corp. | P Buy | 2024-12-02 | 2024-12-03 | 22,828 | $2.24 | $51.1K | 22,828 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2022-11-17 | 2022-11-21 | 20,800 | — | $0 | 20,800 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2021-03-18 | 2021-03-22 | 75,000 | — | $0 | 75,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | P Buy deriv | 2020-03-10 | 2020-03-12 | 3,636 | — | $0 | 3,636 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | P Buy | 2020-03-10 | 2020-03-12 | 3,636 | — | $0 | 5,220 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award | 2019-09-25 | 2019-09-27 | 47,500 | — | $0 | 47,500 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2019-01-14 | 2019-01-16 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ICAD ICAD INC | A Award deriv | 2018-12-21 | 2018-12-27 | 5,000 | $4.00 | $20.0K | 5,000 | SEC↗ |
| ICAD ICAD INC | F Tax w/h | 2018-12-05 | 2018-12-06 | 4,909 | $4.08 | $20.0K | 117,854 | SEC↗ |
| ICAD ICAD INC | A Award | 2018-03-30 | 2018-04-02 | 58,333 | $3.08 | $179.7K | 129,498 | SEC↗ |
| ICAD ICAD INC | F Tax w/h | 2018-03-30 | 2018-04-02 | 6,735 | $3.08 | $20.7K | 122,763 | SEC↗ |
| ICAD ICAD INC | A Award | 2018-03-22 | 2018-03-28 | 25,000 | — | $0 | 71,165 | SEC↗ |
| ICAD ICAD INC | F Tax w/h | 2017-12-05 | 2017-12-07 | 5,409 | $3.52 | $19.0K | 46,165 | SEC↗ |
| ICAD ICAD INC | A Award | 2017-05-04 | 2017-05-08 | 1,574 | — | $0 | 51,574 | SEC↗ |
| ICAD ICAD INC | A Award | 2016-12-05 | 2016-12-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | D To issuer deriv | 2012-12-20 | 2012-12-20 | 20,000 | — | $0 | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | D To issuer deriv | 2012-12-20 | 2012-12-20 | 85,000 | — | $0 | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | D To issuer deriv | 2012-12-20 | 2012-12-20 | 20,000 | — | $0 | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | D To issuer deriv | 2012-12-20 | 2012-12-20 | 19,500 | — | $0 | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | D To issuer deriv | 2012-12-20 | 2012-12-20 | 25,000 | — | $0 | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | D To issuer deriv | 2012-12-20 | 2012-12-20 | 20,000 | — | $0 | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | D To issuer deriv | 2012-12-20 | 2012-12-20 | 37,550 | — | $0 | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | U Tender | 2012-12-20 | 2012-12-20 | 209,150 | $8.00 | $1.67M | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | U Tender | 2012-12-20 | 2012-12-20 | 66,862 | $8.00 | $534.9K | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | M Exercise deriv | 2012-11-13 | 2012-11-13 | 7,500 | — | $0 | 0 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | M Exercise | 2012-11-13 | 2012-11-13 | 7,500 | $1.60 | $12.0K | 276,012 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | F Tax w/h | 2012-05-09 | 2012-05-11 | 1,030 | $6.13 | $6.3K | 268,512 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | F Tax w/h | 2012-03-13 | 2012-03-15 | 2,980 | $5.86 | $17.5K | 269,542 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-09 | 130,000 | — | $0 | 272,522 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | F Tax w/h | 2012-03-07 | 2012-03-09 | 5,151 | $6.05 | $31.2K | 142,522 | SEC↗ |
| DUSA DUSA PHARMACEUTICALS INC | F Tax w/h | 2012-03-05 | 2012-03-07 | 3,329 | $4.65 | $15.5K | 147,673 | SEC↗ |